Penobscot Investment Management Company Inc. Sells 105 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Penobscot Investment Management Company Inc. cut its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 6.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,565 shares of the financial services provider’s stock after selling 105 shares during the period. Penobscot Investment Management Company Inc.’s holdings in iShares Biotechnology ETF were worth $207,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of IBB. HHM Wealth Advisors LLC increased its position in shares of iShares Biotechnology ETF by 200.0% during the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 150 shares during the period. VSM Wealth Advisory LLC bought a new stake in iShares Biotechnology ETF in the 4th quarter valued at $30,000. Bradley & Co. Private Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF in the 4th quarter valued at $32,000. Newbridge Financial Services Group Inc. bought a new position in shares of iShares Biotechnology ETF during the 4th quarter worth about $33,000. Finally, Hager Investment Management Services LLC acquired a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at about $34,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Down 1.4 %

NASDAQ IBB opened at $131.14 on Thursday. The stock has a market cap of $6.20 billion, a P/E ratio of 27.83 and a beta of 0.84. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57. The company’s 50-day simple moving average is $136.23 and its 200 day simple moving average is $139.11.

iShares Biotechnology ETF Increases Dividend

The business also recently announced a dividend, which was paid on Friday, March 21st. Stockholders of record on Tuesday, March 18th were issued a $0.1212 dividend. The ex-dividend date was Tuesday, March 18th. This is a boost from iShares Biotechnology ETF’s previous dividend of $0.06.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.